GENEVA, July 9 -- OBI PHARMA, INC. filed a patent application (US2025/061764) for “SITE-SPECIFIC MULTI-PAYLOAD ANTIBODY-DRUG CONJUGATES AND PREPARATION THEREOF”. With publication no. WO/2026/148079, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....